Patent · US Expired

Pharmaceutical compositions for immunotherapy containing antibodies which specifically recognize the MHCII antigen of a patient to be treated

US6294167A · kind A · utility

19Cited by

1References

13Claims

0Family size

Assignee

GSF FORSCHUNGSZENTRUM FUR UMWELT UND GESUNDHEIT GMBH · DE

Inventors

Horst Lindhofer · Puchheim, DE
Stefan Thierfelder · Eichenau, DE

Key dates

Filing date	Nov 23, 1998
Grant date	Sep 25, 2001
Priority date	—
Expiry date	Nov 23, 2018

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention concerns medicaments containing antibodies which have at least one specificity and detect the MHCII antigen of a patient to be treated. The invention further concerns antibodies with two or more specificities which detect the MHCII antigen of a patient, and diagnostic compositions containing these antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.